A study conducted in immunodeficient mice bearing subcutaneous xenografts of Raji Burkitt lymphoma demonstrated that pelabresib inhibits the expression of MYC in tumor tissue in a dose-dependent manner. This evidence concerns the gene MYC and Burkitt lymphoma.